Evidence map›Paper›PMID 32203125›Full record

ArticleThe Journal of antibiotics2020

A novel chresdihydrochalcone from Streptomyces chrestomyceticus exhibiting activity against Gram-positive bacteria.

Weiyi She, Wenkang Ye, Yusheng Shi, Le Zhou, Zhihong Zhang, Feng Chen, Pei-Yuan Qian

Abstract read
PubMed Publisher
In one paragraph

Article in The Journal of antibiotics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. NewTheScientificWorldJournal · 2025
    Pooled it
  2. Article
  3. Article
  4. In Silico Screening ofBiologics : targets & therapy · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Recently Discovered Secondary Metabolites fromMolecules (Basel, Switzerland) · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Weiyi She *SZU-HKUST Joint Ph.D. Program in Marine Environmental Science, Shenzhen University, Shenzhen, China.
Wenkang Ye *SZU-HKUST Joint Ph.D. Program in Marine Environmental Science, Shenzhen University, Shenzhen, China.
Yusheng ShiDepartment of Ocean Science, Division of Life Science and Hong Kong Branch of the Southern Marine Science and Engineering Guangdong Laboratory, The Hong Kong University of Science and Technology, Hong Kong, China.
Le ZhouDepartment of Chemistry, The University of Hong Kong, Pokfulam Road, Hong Kong, China.
Zhihong ZhangDepartment of Chemistry, The Hong Kong University of Science and Technology, Hong Kong, China.
Feng ChenInstitute for Advanced Study, Shenzhen University, 518060, Shenzhen, China. sfchen@szu.edu.cn.
Pei-Yuan QianDepartment of Ocean Science, Division of Life Science and Hong Kong Branch of the Southern Marine Science and Engineering Guangdong Laboratory, The Hong Kong University of Science and Technology, Hong Kong, China. boqianpy@ust.hk.ORCID http://orcid.org/0000-0003-4074-9078
Hong Kong University of Science and Technology · HKShenzhen University · CNUniversity of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbial-derived natural products provide unique bioactivities and serve as a unique source of drug leads. In the present study, we isolated one new chresdihydrochalcone (1), one new chresphenylacetone (2), and one known streptimidone (3) from Streptomyces chrestomyceticus BCC 24770 using antibacterial activity-guided isolation and purification procedures. We determined their molecular weights using MS and HRMS and elucidated their chemical structures from their 1D and 2D NMR and electronic circular dichroism (ECD) spectra. Compound 1 showed moderate inhibitory activities against the Gram-positive bacteria Methicillin-resistant Staphylococcus aureus, Bacillus subtilis, and Micrococcus luteus. Cytotoxicity and hemolytic activity were not observed at a concentration of up to 100 μg ml

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsBacillus subtilisGram-Positive BacteriaMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMicrococcus luteusStreptomycesAnti-Bacterial AgentsAnti-Infective Agents

Identifiers

PMID32203125
OpenAlexW3011859332

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.